PAVmed (PAVM) Preferred Shares (2017 - 2025)

PAVmed's Preferred Shares history runs 9 years deep, the most recent figure standing at $3.7 million for Q4 2025.

• In Q4 2025, Preferred Shares changed N/A year-over-year to $3.7 million; the TTM figure through Dec 2025 stood at $3.7 million (changed N/A YoY), while the FY2025 annual figure was $3.7 million, changed N/A from the prior year.
• Preferred Shares was $3.7 million for Q4 2025 at PAVmed, up from $3.6 million in the prior quarter.
• In the past five years, Preferred Shares ranged from a high of $3.7 million in Q4 2025 to a low of $2.4 million in Q3 2021.
• Historically, Preferred Shares has averaged $2.9 million across 5 years, with a median of $2.8 million in 2023.
• The sharpest annual moves came in 2021 and 2022: Preferred Shares decreased 4.65% in 2021, then increased 11.56% in 2022.
• A 5-year view of Preferred Shares shows it stood at $2.4 million in 2021, then grew by 11.41% to $2.7 million in 2022, then advanced by 11.06% to $3.0 million in 2023, then advanced by 5.28% to $3.2 million in 2024, then gained by 16.31% to $3.7 million in 2025.
• The last three Preferred Shares figures came in at $3.7 million (Q4 2025), $3.6 million (Q3 2025), and $3.5 million (Q2 2025), per Business Quant data.